Global Cord Blood Corporation (CO) — Financial statements
Income statement, balance sheet, and cash flow for Global Cord Blood Corporation — annual and quarterly history with growth and margin analysis.
| Metric (CNY Millions) | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,243↑7.2% | 1,160↓5.1% | 1,221↑23.8% | 987↑5.3% | 937 | |
| Cost of Revenue | 183↑2.4% | 179↓5.4% | 189↑1.7% | 186↑2.5% | 181 | |
| Gross Profit | 1,060↑8.1% | 981↓5.0% | 1,032↑28.9% | 801↑6.0% | 755 | |
| Operating Expenses | ||||||
| R&D Expenses | 22↓6.2% | 24↑12.6% | 21↑43.7% | 15↑15.5% | 13 | |
| General & Administrative Expenses | 187↑7.3% | 174↓8.3% | 190↑12.4% | 169↓30.5% | 244 | |
| Selling & Marketing Expenses | 242↑1.7% | 238↓9.3% | 262↑11.4% | 235↑7.2% | 219 | |
| SG&A Expenses | 429↑4.1% | 412↓8.9% | 452↑11.8% | 404↓12.6% | 463 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 4 | |
| Operating Expenses | 451↑3.5% | 436↓7.9% | 473↑12.9% | 419↓11.9% | 475 | |
| Total Costs & Expenses | 634↑3.2% | 615↓7.2% | 662↑9.5% | 605↓7.9% | 657 | |
| Operating Results | ||||||
| Operating Income | 609↑11.7% | 545↓2.5% | 559↑46.5% | 382↑36.4% | 280 | |
| Depreciation & Amortization | 48↓2.4% | 49↓0.7% | 49↓5.6% | 52↑3.5% | 51 | |
| EBITDA | 629↑5.9% | 594↓2.4% | 608↑40.2% | 434↑22.7% | 354 | |
| EBIT | 609↑11.7% | 545↓2.5% | 559↑46.5% | 382↑24.4% | 307 | |
| Interest & Other Income | ||||||
| Net Interest Income | 33↑5.5% | 31↑21.8% | 25↑0.2% | 25↑35.6% | 19 | |
| Interest Income | 33↑5.5% | 31↑21.8% | 25↑0.2% | 25↑15.4% | 22 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 3 | |
| Non-Operating Income | 20 | 0.00 | 0.00 | 0.00↑100.0% | -27 | |
| Other Income / Expenses | 19↓71.2% | 66↑233.1% | 20↑178.5% | -25↓206.4% | 24 | |
| Income Before Tax | 628↑2.8% | 611↑5.5% | 579↑62.4% | 356↑17.4% | 304 | |
| Income Tax Expense | 118↑25.2% | 95↓6.5% | 101↑65.0% | 61↓2.2% | 63 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 509↓1.3% | 516↑8.1% | 478↑61.8% | 295↑22.6% | 241 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 501↓1.4% | 508↑8.0% | 471↑61.7% | 291↑22.8% | 237 | |
| Bottom-Line Net Income | 501↓1.4% | 508↑8.0% | 471↑61.7% | 291↑22.8% | 237 | |
| EPS (Basic) | 4.12↓1.4% | 4.18↑8.0% | 3.87↑61.3% | 2.40↑20.6% | 1.99 | |
| EPS (Diluted) | 4.12↓1.4% | 4.18↑8.0% | 3.87↑61.3% | 2.40↑20.6% | 1.99 | |
| Weighted Average Shares | 122↑0.0% | 122↑0.0% | 122↑0.2% | 121↑1.8% | 119 | |
| Weighted Average Diluted Shares | 122↑0.0% | 122↑0.0% | 122↑0.2% | 121↑1.8% | 119 | |
* All figures in Millions of CNY, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.